Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?
dc.contributor.author | Doğan, Umuttan | |
dc.date.accessioned | 2020-03-26T17:45:58Z | |
dc.date.available | 2020-03-26T17:45:58Z | |
dc.date.issued | 2010 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | The prevalence of atrial fibrillation (AF) is high and it is expected to increase in the near future (1). AF is a strong independent risk factor for ischemic stroke and systemic arterial embolisation (2). Oral anticoagulation (OAC) has been shown to decrease the risk of stroke. In a meta-analysis of 6 randomized trials including 2900 participants, the estimated relative risk reduction is reported as 64% (3). Despite the evident benefits, OAC is underused even in high risk AF patients (4, 5). | |
dc.description.abstract | [Abstract not Available] | en_US |
dc.identifier.citation | Doğan, U., (2010). Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?. Anadolu Kardiyoloji Dergisi, (10), 41-42. Doi: 10.5152/akd.2010.009 | |
dc.identifier.endpage | 42 | en_US |
dc.identifier.issn | 1302-8723 | en_US |
dc.identifier.issn | 1308-0032 | en_US |
dc.identifier.pmid | 20150003 | en_US |
dc.identifier.startpage | 41 | en_US |
dc.identifier.uri | http://www.trdizin.gov.tr/publication/paper/detail/TVRBd05EazRPQT09 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/24235 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000275102800009 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.institutionauthor | Doğan, Umuttan | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Anadolu Kardiyoloji Dergisi | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Kalp ve Kalp Damar Sistemi | en_US |
dc.title | Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved? | en_US |
dc.title.alternative | Atriyal Fibrilasyonda Oral Antikoagülan Tedavi: Sorunlar Çözüldü Mü? | en_US |
dc.type | Other | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 4235.pdf
- Boyut:
- 79.39 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Makale Dosyası